This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: The Innovations of Robert Pachlinger
Introduction
Robert Pachlinger is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. With a total of two patents to his name, Pachlinger's work is recognized for its potential impact on healthcare.
Latest Patents
Pachlinger's latest patents focus on anti-Factor IX Padua antibodies. These patents provide constructs that include antibodies and antigen-binding fragments. The inventions also encompass related polypeptides, conjugates, and kits. These innovations may be utilized in methods for detecting Factor IX Padua in various samples.
Career Highlights
Robert Pachlinger is currently associated with Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work at Takeda emphasizes the importance of innovative solutions in the medical field. Pachlinger's expertise in antibody development positions him as a key player in advancing therapeutic options.
Collaborations
Pachlinger has collaborated with esteemed colleagues such as Dirk Voelkel and Hanspeter Rottensteiner. These partnerships enhance the research and development efforts within the pharmaceutical industry.
Conclusion
Robert Pachlinger exemplifies the spirit of innovation in biotechnology through his patents and collaborations. His contributions to the field are paving the way for advancements in medical diagnostics and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile